Back
Alnylam Pharmaceuticals Stock Price Chart
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.
Sell
32
ALNY
Alnylam Pharmaceuticals
Last Price:
148.01
Seasonality Move:
19.79%
7 Day Trial
ALL ACCESS PASS
$
7
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
Alnylam Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 151.52 | Sell |
| 20-day SMA: | 147.88 | Buy |
| 50-day SMA: | 149.32 | Buy |
| 200-day SMA: | 170.05 | Sell |
| 8-day EMA: | 150.53 | Sell |
| 20-day EMA: | 149.62 | Buy |
| 50-day EMA: | 152.03 | Sell |
| 200-day EMA: | 168.02 | Sell |
Alnylam Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.36 | Buy |
| Relative Strength Index (14 RSI): | 50.32 | Buy |
| Chaikin Money Flow: | -266250 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (144.97 - 152.17) | Buy |
| Bollinger Bands (100): | (145.48 - 180.92) | Sell |
Alnylam Pharmaceuticals Technical Analysis
| Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Alnylam Pharmaceuticals Stock
Is Alnylam Pharmaceuticals Stock a Buy?
- Alnylam Pharmaceuticals share price is 149.89 while ALNY 8-day simple moving average is 151.52, which is a Sell signal.
- The stock price of ALNY is 149.89 while Alnylam Pharmaceuticals 20-day SMA is 147.88, which makes it a Buy.
- Alnylam Pharmaceuticals 50-day simple moving average is 149.32 while ALNY share price is 149.89, making it a Buy technically.
- ALNY stock price is 149.89 and Alnylam Pharmaceuticals 200-day simple moving average is 170.05, creating a Sell signal.
ALNY Technical Analysis vs Fundamental Analysis
Sell
32
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a Sell
The current Alnylam Pharmaceuticals [ALNY] share price is $149.89. The Score for ALNY is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Alnylam Pharmaceuticals Stock Info
Market Cap:
18.96B
Price in USD:
149.89
Share Volume:
517K
Alnylam Pharmaceuticals 52-Week Range
52-Week High:
218.88
52-Week Low:
141.98
Sell
32
Alnylam Pharmaceuticals (ALNY)
is a Sell
Alnylam Pharmaceuticals Share Price Forecast
-
What is the Alnylam Pharmaceuticals stock price today?
The Alnylam Pharmaceuticals stock price is 149.89 USD today. -
Will ALNY stock go up or go down?
Alnylam Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Alnylam Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Alnylam Pharmaceuticals is overvalued.
Is Alnylam Pharmaceuticals Stock a Buy?
- Alnylam Pharmaceuticals share price is 149.89 while ALNY 8-day exponential moving average is 150.53, which is a Sell signal.
- The stock price of ALNY is 149.89 while Alnylam Pharmaceuticals 20-day EMA is 149.62, which makes it a Buy.
- Alnylam Pharmaceuticals 50-day exponential moving average is 152.03 while ALNY share price is 149.89, making it a Sell technically.
- ALNY stock price is 149.89 and Alnylam Pharmaceuticals 200-day simple moving average is 168.02, creating a Sell signal.
Fundamental Analysis of Alnylam Pharmaceuticals
Is Alnylam Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.14 per share, a decrease this year of $0.52 per share, and an increase next year of $1.84 per share.
Technical Analysis of Alnylam Pharmaceuticals
Should I short Alnylam Pharmaceuticals stock?
- ALNY Moving Average Covergence Divergence (MACD) indicator is 0.36, suggesting Alnylam Pharmaceuticals is a Buy
- Alnylam Pharmaceuticals Relative Strength Index (RSI) is 50.32, which suggest Alnylam Pharmaceuticals is overbought
- The Bollinger Bands (25) for Alnylam Pharmaceuticals is (144.97 - 152.17), which suggest Alnylam Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Alnylam Pharmaceuticals is (145.48 - 180.92), which suggest Alnylam Pharmaceuticals is a Sell
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.